======= BCL9 ======= == Gene Information == * **Official Symbol**: BCL9 * **Official Name**: BCL9 transcription coactivator * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=607|607]] * **UniProt**: [[https://www.uniprot.org/uniprot/O00512|O00512]] * **Interactions**: [[https://thebiogrid.org/search.php?search=BCL9&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20BCL9|Open PubMed]] * **OMIM**: [[https://omim.org/entry/602597|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Involved in signal transduction through the Wnt pathway. Promotes beta-catenin's transcriptional activity (By similarity). {ECO:0000250, ECO:0000269|PubMed:11955446}. |BCL9| |myotube differentiation involved in skeletal muscle regeneration| |beta-catenin-TCF complex| |beta-catenin-TCF complex assembly| |skeletal muscle tissue regeneration| |skeletal muscle cell differentiation| |myotube differentiation| |tissue regeneration| |cis-Golgi network| |somatic stem cell population maintenance| |beta-catenin binding| |canonical Wnt signaling pathway| |regulation of transforming growth factor beta receptor signaling pathway| |regulation of cellular response to transforming growth factor beta stimulus| |skeletal muscle tissue development| |skeletal muscle organ development| |stem cell population maintenance| |maintenance of cell number| |regeneration| |striated muscle cell differentiation| |regulation of transmembrane receptor protein serine/threonine kinase signaling pathway| |muscle cell differentiation| |regulation of cellular response to growth factor stimulus| |transcription coactivator activity| |striated muscle tissue development| |muscle organ development| |muscle tissue development| |cell-cell signaling by wnt| |Wnt signaling pathway| |developmental growth| |growth| |cell surface receptor signaling pathway involved in cell-cell signaling| |muscle structure development| |wound healing| |response to wounding| |cell-cell signaling| |positive regulation of transcription by RNA polymerase II| |positive regulation of transcription, DNA-templated| |protein-containing complex assembly| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |positive regulation of RNA metabolic process| |tissue development| |protein-containing complex subunit organization| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp102|Nifuroxazide 5μM R03 exp102]]|1.81| |[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|2.22| |[[:results:exp499|LY2090314 0.003μM R08 exp499]]|3.62| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 4877 * **Expression level (log2 read counts)**: 5.24 {{:chemogenomics:nalm6 dist.png?nolink |}}